Sales & Marketing 7 commercial, sales, and marketing predictions for 2023 In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs).
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.